Kelly Lancaster
2PUBLICATIONS
36CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Mar 03, 2025
XMT-2056, a HER2-Directed STING Agonist Antibody-Drug Conjugate, Induces Innate Antitumor Immune Responses by Acting on Cancer Cells and Tumor-Resident Immune Cells.Raghida A Bukhalid, Jeremy R Duvall, Kelly Lancaster
|Sep 29, 2023
Site-Specific Dolasynthen Antibody-Drug Conjugates Exhibit Consistent Pharmacokinetic Profiles across a Wide Range of Drug-to-Antibody Ratios.Susan M Clardy, Alex Uttard, Bingfan Du
Pageof 1
Frequent Collaborators
2 joint publications
Dorin Toader
2 joint publications
Kalli C Catcott
2 joint publications
Elizabeth Ditty
2 joint publications
Jeffrey Zurita
2 joint publications
Naniye Malli Cetinbas
2 joint publications
Timothy B Lowinger
2 joint publications
Marc Damelin
2 joint publications
Ling Xu
1 joint publications
Alex Uttard
1 joint publications
Bingfan Du
